- Service Name
GlucoseReady™
- Industry
Healthcare, Clinical Trials, Technology, Life Sciences
- Main Value Proposition
GlucoseReady™ offers a streamlined approach to diabetes clinical trials, enhancing data quality and operational efficiency through innovative technology.
- Description
GlucoseReady™ is a comprehensive solution designed for diabetes trials, integrating continuous glucose monitoring (CGM) and electronic Clinical Outcome Assessments (eCOA) with behavioral management. It aims to enhance the efficiency and quality of clinical trials in diabetes and related therapeutic areas.
- Key Features
Integration of CGM/BGM and eCOA for diabetes trials; Behavioral management tools for obesity trials; Rapid study build timeline reduced to 10 days; eSource ecosystem for unified data capture and analytics
- Use Cases
Primary scenarios include conducting decentralized clinical trials, improving patient engagement in diabetes research, and facilitating rapid data collection in various therapeutic areas.
- Competitive advantages
Faster study build timelines compared to traditional methods; Comprehensive data capture from multiple sources, including direct patient input; Expertise across various therapeutic areas, improving trial outcomes
- Strengths
Key strengths include a robust eSource platform that enhances data quality, a focus on patient engagement, and a proven track record in complex therapeutic areas.
- Positioning
GlucoseReady™ positions itself as a leader in the clinical trial technology space, focusing on innovative solutions that enhance data quality and operational excellence.
- Audience
Target users include clinical trial sponsors, contract research organizations (CROs), and healthcare professionals involved in diabetes and related therapeutic research.
- CTA
DOWNLOAD WHITE PAPER
- Tags
eCOA
Clinical Trials
Diabetes
Digital Health
- Tagline
GlucoseReady™: Diabetes
- Tone of Voice
Professional, innovative, reliable
- Differentiation
The service uniquely combines advanced eCOA technology with behavioral management and CGM/BGM integration, setting a new standard for speed and accuracy in clinical trials.
- Brand Positioning
Clinical ink is recognized for its commitment to advancing clinical research through technology, emphasizing responsiveness, flexibility, and subject matter expertise.
- Founded
2006-01-01
- Founders
Doug Pierce
Tommy Littlejohn